LNC
32
3
PEP
33
-3
ORLY
48
-4
TROW
50
2
FOX
70
-3
GILD
58
2
KSS
42
3
PRU
50
3
VIX
15
7
FDX
40
4
AIV
43
2
BIIB
42
2
PSX
29
2
DLTR
59
4
GOOGL
64
-2
TGNA
53
3
ZTS
43
3
EXR
33
2
EQR
39
2
MMM
40
3
LNC
32
3
PEP
33
-3
ORLY
48
-4
TROW
50
2
FOX
70
-3
GILD
58
2
KSS
42
3
PRU
50
3
VIX
15
7
FDX
40
4
AIV
43
2
BIIB
42
2
PSX
29
2
DLTR
59
4
GOOGL
64
-2
TGNA
53
3
ZTS
43
3
EXR
33
2
EQR
39
2
MMM
40
3
Financhill
Back

Prenetics Global 10K Form

Buy
57

PRE
Prenetics Global

Last Price:
$5.76
Seasonality Move:
-17.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRE News And Ratings

See the #1 stock for the next 7 days that we like better than PRE

PRE Financial Statistics

Sales & Book Value

Annual Sales: $21.7M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $14.63
Price / Book: 0.4

Profitability

EPS (TTM): -3.99000
Net Income (TTM): $-46.9M
Gross Margin: $8.8M
Return on Equity: -23.16%
Return on Assets: -18.87%

Prenetics Global Earnings Forecast

Key Prenetics Global Financial Ratios

  • The Gross Profit Margin over the past 5 years for PRE is 40.61%.
  • The Selling, General & Administrative Expenses for PRE have been equal to 228.50% of Gross Profit Margin.
  • The Research & Development expenses have been 53.64% of Revenue.
  • The Interest Expense is -0.19% of Operating Income.
  • The Net Earning history of PRE is -288.48% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 6 years.

Prenetics Global Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: PRE
CUSIP: G6852T
Website: prenetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.4
Quick Ratio: 1.11

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRE Technical Analysis vs Fundamental Analysis

Buy
57
Prenetics Global (PRE) is a Buy

Is Prenetics Global a Buy or a Sell?

  • Prenetics Global stock is rated a Buy
    The current Prenetics Global [PRE] share price is $5.79. The Score for PRE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.